A Democratic congressman says the Trump administration presents a “revolutionary” opportunity to advance drug policy reform around marijuana and psychedelics.
In an interview with Marijuana Moment on Thursday, Rep. Lou Correa (D-CA) discussed the prospect of cannabis rescheduling under President Donald Trump, who said recently that a decision on the issue would be announced within weeks.
“I guarantee you that the administration has been weighing in on these issues” as GOP lawmakers consider their stances on marijuana reforms, Correa said, adding that while former President Joe Biden initiated the rescheduling review that led to a Schedule III reclassification recommendation, “it never happened.”
“With this administration, you have a lot of the high-level ranking members and secretaries saying cannabis, mushrooms and psychedelics are good,” he said. “This is revolutionary—the first time…since we declared the war on drugs in the 70s that we’re actually having common sense come back to drug policy.”
Correa, a founding co-chair of the Congressional Psychedelic Advancing Therapies (PATH) Caucus, said that while his preference would be for the federal government to remove marijuana from the Controlled Substances Act (CSA) altogether rather than see it merely rescheduled, “I’ll let that be answered by the experts who’ll be doing
Read full article on Marijuana Moment
